The Global Health Body Sounds Warning Over Severe Lack of Weight-Loss Injections

Fewer than one in 10 patients who could benefit from obesity jabs including Wegovy are able to get them, warns the WHO as it publishes its inaugural recommendations on the therapies.

Considering over a billion people worldwide now living with obesity, it is urging more widespread and fairer availability to these injectable treatments.

Based on forecasts, in excess of 2,000,000,000 could be living with obesity by 2030 without intervention.

"Our new guidance acknowledges that excess weight is a long-term condition that can be treated with holistic and ongoing care," said its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and distribution challenges are major hurdles to universal availability to the jabs that can help people shift considerable weight, notes the organization.

Skinny Jab Scarcity

Despite the present most optimistic outlook, the manufacturing of GLP-1 therapies would only suffice for about 100 million people – under 10% of eligible patients, per the WHO.

The advice urges governments and firms to widen availability, by strategies like patent sharing.

The intellectual property rights on a key compound – the primary ingredient of a leading brand – is set to lapse in several nations in 2026.

The Way Obesity Jabs Operate

GLP-1 drugs mimick a body's own hormone to reduce digestion speed, suppress the appetite and enhance the sense of being full so users reduce food intake.

Patients usually begin shedding pounds after several weeks of starting on the once-weekly jabs.

Studies suggests users may put most of the weight back on a year later of halting the treatment, when their typical food cravings come back.

To be overweight or obese raises your chance for contracting health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.

Obesity concerns individuals in all nations and was linked to over three and a half million deaths worldwide in 2024, per the WHO.